Researchers identified the patient groups most likely to benefit before starting treatment, giving employers a clinical basis for coverage as costs climb.
Recap by typeshit. Full story at Employee Benefit News.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
With GLP-1 medications already shifting what people buy, the piece asks what happens to the morning meal and the brands that sell it.
The drugs join more than 250 no-cost prescriptions on Walmart's medical plans next year, subject to prior approval.
Loading…